CD155 overexpression is a hallmark observed in multiple malignancies, including lung adenocarcinoma,[56] colorectal cancer,[57] pancreatic cancer,[58] and high‐grade gliomas, such as GBM (Grade IV),[45, 59] and promotes tumor migration and invasion. The gene discussed is PVR; the disease is central nervous system cancer.